Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions

Not Applicable

Completed

• Conditions: Diagnosis, Dual (Psychiatry)
• Interventions: Behavioral: Animal-assisted therapy (AAT); Other: usual treatment

• Registration Number: NCT05103865
• Lead Sponsor: Miguel Monfort Montolio

Brief Summary

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the efectiveness of an AAT program in patients diagnosed with substance abuse disorder and associated mental disorders (dual pathology).

Detailed Description

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with substance use disorder and schizophrenia spectrum disorder.

Study Timeline

• Study Start: 2015-11-03
• Primary Completion: 2019-05-20
• Study Completion: 2019-09-10
• Status Verified: 2021-10
• Study First Submitted: 2021-10-20
• Study First Submitted QC: 2021-10-30
• Last Update Submitted: 2021-10-30
• Study First Posted: 2021-11-02
• Last Update Posted: 2021-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

• Meeting DSM-5 criteria for substance abuse disorder and the presence of schizophrenia
• Voluntary participant in the study and having signed the informed consent

Exclusion Criteria

• Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier)
• Animal-specific phobia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental group (EG)	Animal-assisted therapy (AAT)	-
Control group	usual treatment	-

Primary Outcome Measures

Name	Time	Method
Barrat impulsiveness scale (BIS-11)	Change from impulsiveness at 3-6-9 months (12 minutes)	This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained.
Positive and negative symptom scale (PANSS)	Change from Positive and negative symptom at 3-6-9 months (12 minutes)	It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders.
The Life Skills Profile questionnaire (LSP)	Change from Life Skills at 3-6-9 months (12 minutes)	This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behaviour and autonomous life
Rosenberg Self-Esteem Scale	Change from self.-esteem at 3-6-9 months (12 minutes)	The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).
Calgary Depresión Scale for Schizophrenia (CDSS)	Change from Depresión at 3-6-9 months (12 minutes)	El cuestionario es un intrumento estructurado, adminisitrado por un clínico de forma heteroaplicada para población adulta, con un tiempo aproximado de administración de entre 10 y 30 minutos, y aborada el área terapéutica relativa a la sintomatología de los trastornos depresivos.